Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glaukos Corp (NY: GKOS )

65.13 +1.24 (+1.94%)
Official Closing Price Updated: 7:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 449,386
Open 63.86
Bid (Size) 64.80 (1)
Ask (Size) 65.67 (1)
Prev. Close 63.89
Today's Range 63.54 - 65.25
52wk Range 40.45 - 80.28
Shares Outstanding 48,799,581
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Ratings for Glaukos
Via Benzinga
4 Analysts Have This to Say About Glaukos
Via Benzinga

Performance

YTD
+48.43%
+48.43%
1 Month
-6.19%
-6.19%
3 Month
-13.03%
-13.03%
6 Month
+4.85%
+4.85%
1 Year
+33.85%
+33.85%

More News

Read More
Glaukos Announces Participation in Stifel Healthcare Conference
From Glaukos Corporation
Via Business Wire
Glaukos Announces Third Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
From Glaukos Corporation
Via Business Wire
8 Analysts Have This to Say About Glaukos
Via Benzinga
Glaukos's Earnings Outlook
Via Benzinga
Analyst Ratings for Glaukos
Via Benzinga
Where Glaukos Stands With Analysts
Via Benzinga
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire
Glaukos Announces Second Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst
Via Benzinga
Stifel Maintains Buy Rating for Glaukos: Here's What You Need To Know
Via Benzinga
8 Analysts Have This to Say About Glaukos
Via Benzinga
Analyst Expectations for Glaukos's Future
Via Benzinga
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
From Glaukos Corporation
Via Business Wire
These 2 Soaring Stocks Finished the Week Strong
Via The Motley Fool
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
Via Benzinga
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
From Glaukos Corporation
Via Business Wire
Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in the William Blair Growth Stock Conference
From Glaukos Corporation
Via Business Wire
Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.